Metraipolis › archive › dc_bfd02fe15d46

Novel bioactive compounds in the treatment of osteoporosis: chemistry-driven discovery from preclinical validation to clinical translation — Europe PMC PMID:42827864

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42827864
DOI
10.3389/fchem.2026.1917991
License (as archived)
solo-consultazione
Archived
2026-10-06T12:56:44.270Z
SHA-256 of the archived text
b69045bf422b0e568f184f2fe863c5f07b43090814e09c7e71889ef8cc1c0f5a
Stable URL of this page
https://metraipolis.com/documento/dc_bfd02fe15d46

How to cite

Novel bioactive compounds in the treatment of osteoporosis: chemistry-driven discovery from preclinical validation to clinical translation — Europe PMC PMID:42827864 — Europe PMC (en), https://europepmc.org/article/MED/42827864 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bfd02fe15d46 (Metraipolis archive dc_bfd02fe15d46, sha256 b69045bf422b0e568f184f2fe863c5f07b43090814e09c7e71889ef8cc1c0f5a)
BibTeX
@misc{dcbfd02fe15d46,
  title = {Novel bioactive compounds in the treatment of osteoporosis: chemistry-driven discovery from preclinical validation to clinical translation — Europe PMC PMID:42827864},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42827864},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bfd02fe15d46; sha256 b69045bf422b0e568f184f2fe863c5f07b43090814e09c7e71889ef8cc1c0f5a},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42827864. Agents can read the archived copy with the MCP tool read_document.